Table 2 The therapeutic response in CHB patients after treatment.
Treatment course | Responders (N = 8) | Non-responders (N = 16) | ||
|---|---|---|---|---|
HBeAg seroconversion | Non-HBeAg seroconversion | HBeAg seroconversion | Non-HBeAg seroconversion | |
24 weeks | 3 | 2 | 0 | 9 |
48 weeks | 3 | 0 | 0 | 7 |